Endocrine News Podcast · Endocrine Society

ENP109: Anti-Obesity Medications (CME credit available)

January 7, 2026·13 min·1 clip

New anti-obesity medications show a 20% reduction in major cardiovascular risk, according to the CELEP trial results.

Host Aaron Lohr interviews Dr. Geetanjali Srivasta, an obesity medicine specialist, about the evolution, efficacy, and clinical use of modern anti-obesity medications. They discuss the concept of 'complicated obesity,' the shift from stigma to disease recognition, and strategic approaches to pharmacotherapy including new GLP-1 agonists.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Endocrine News Podcast